References
- Yinon Y, Farine D, Yudin MH. Cytomegalovirus infection in pregnancy. J Obstet Gynaecol Can. 2018;140:134–141.
- Fowler KB, Boppana S. Congenital cytomegalovirus infection. Semin Perinatol. 2018;42(3):149–115.
- Grosse SD, Ross DS, Dollard SC. Congenital cytomegalovirus (CMV) infection as a cause of permanent bilateral hearing loss: a quantitative assessment. J Clin Virol. 2008;41(2):57–62.
- Pass RF, Fowler KB, Boppana S. Clinical importance of cytomegalovirus infection: an overview. In: Landini MP, ed. Progress in Cytomegalovirus research. New York, NY: Elsevier Science Publisher; 1991. p. 3–10.
- Kanji A, Khoza-Shangase K, Petrocchi-Bartal, L et al. Feasibility of infant hearing screening from a developing country context: the South African experience. Hear Bal Commun. 2018; 16(4):263–270.
- Fowler KB, McCollister FP, Sabo DL, on behalf of the CHIMES Study, et al. A targeted approach for congenital Cytomegalovirus screening within newborn hearing screening. Paediatrics. 2017;139(2):e20162128.
- Rechavi E, Somech R. Maturation of the immune system in the fetus and the implications for congenital CMV. Best Pract Res Clin Obstet Gynaecol. 2019;60:35–41.
- Lazzarotto T, Blázquez-Gamero D, Delforge M-L, et al. Congenital Cytomegalovirus infection: a narrative review of the issues in screening and management from a panel of European experts. Front Pediatr. 2020;8:13–31.
- Ohyama S, Morioka I, Fukushima S, et al. Efficacy of valganciclovir treatment depends on the severity of hearing dysfunction in symptomatic infants with congenital Cytomegalovirus infection. IJMS. 2019; 20(6):1388.
- Kimberlin DW, Jester PM, Sanchez PJ, National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group, et al. Valganciclovir for symptomatic congenital Cytomegalovirus disease. N Engl J Med. 2015;372(10):933–943.
- Joint Committee on Infant Hearing. Year 2019 position statement: principles and guidelines for early hearing detection and intervention programs. J Early Hear Detect Interven. 2019;4(2):1–44.
- Gruppo multidisciplinare Malattie infettive in ostetricia-ginecologia e neonatologia. Linee guida SIN. Available from: http://www.simast.itlguida/percorsi-diagnostico-assist/cyitomegalovirus.
- Lim Y, Lyall H. Congenital cytomegalovirus- who, when, what-with and why to treat? J Infection. 2017;74:589–594.
- Cannon MJ, Schmid DS, Hyde TB. Review of Cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol. 2010;20(4):202–213.
- Vancor E, Shapiro ED, Loyal J. Results of a targeted screening program for congenital Cytomegalovirus infection in infants who fail newborn hearing screening. J Paed Infec Dis Soc. 2019;8(1):55–59.
- Foulon I, De Brucker Y, Buyl R, et al. Hearing loss with congenital Cytomegalovirus infection. Paediatrics. 2019;144(2):e20183095.
- Beswick R, David M, Higashi H, et al. Integration of congenital cytomegalovirus screening within a newborn hearing screening programme. J Paediatr Child Health. 2019;55(11):1381–1388.
- Diener ML, Zuck CD, Browining McVicar S, et al. Outcomes from a hearing-targeted Cytomegalovirus screening program. Paediatrics. 2017;39:2.
- Gievers LL, Holmes AV, Loyal J, et al. Ethical and public health implications of targeted screening for congenital Cytomegalovirus. Pediatrics. 2020;146(1):e20200617.
- Marsico C, Kimberlin DW. Congenital Cytomegalovirus infection: advances and challenges in diagnosis, prevention and treatment. Ital J Paediatr. 2017;43:38.